Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at :

NCT ID NCT05584709
Title Study to Access Anti-CD38 Anibody Drug in Patients With Advanced Solid Tumors
Recruitment Not yet recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Sorrento Therapeutics, Inc.
Age Groups: adult | senior
Covered Countries USA

No variant requirements are available.